Management of malignant pleural effusions

Seminars in Respiratory and Critical Care Medicine

Volumn 29, Issue 4, 2008, Pages 405-413

  Spector, Marcelo ^a   Pollak, Jeffrey S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fluid; Interventional procedures; Malignant; Pleura; Pleural effusion; Tunneled pleural catheter

Indexed keywords

BLEOMYCIN; DOXYCYCLINE; LIDOCAINE; STREPTOKINASE; TALC; TETRACYCLINE;

BREAST CANCER; CATHETER; CLINICAL FEATURE; CYTOLOGY; HUMAN; LUNG CANCER; PATHOPHYSIOLOGY; PERITONEUM PLEURA SHUNT; PLEURA BIOPSY; PLEURA EFFUSION; PLEURECTOMY; PLEURODESIS; PRIORITY JOURNAL; REVIEW; SCLEROTHERAPY; SHUNTING; SYSTEMIC THERAPY; THORACOCENTESIS; THORACOSCOPY; THORAX DRAINAGE; TUBE; TUBE THORACOSTOMY; TUNNELED PLEURAL CATHETER;

CHEST TUBES; DRAINAGE; HUMANS; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; RADIOGRAPHY, INTERVENTIONAL; SCLEROTHERAPY; THROMBOLYTIC THERAPY;

EID: 48249097872     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1081283     Document Type: Review

References (67)

1. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006;54:1-9
2. American Thoracic Society. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000;162:1987-2001
3. Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58(Suppl II):ii29-ii38
4. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A. Management of malignant pleural effusions. Drugs 1998;55:47-58
5. Tattersall M. Management of malignant pleural effusion. Aust N Z J Med 1998;28:394-396
6. Sears D, Hajdu SI. The cytologic diagnosis of malignant neoplasm in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97
7. van de Molengraft FJ, Voojis GP. Survival of patients with malignancy-associated effusions. Acta Cytol 1989;33:911-916
8. Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000;117:79-86
9. Judson MA, Sahn SA. Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Crit Care Med 1995;16:346-353
10. Sahn SA. State of the art: the pleura. Am Rev Respir Dis 1988;138:184-234
11. Lynch TJ Jr. Management of malignant pleural effusions. Chest 1993;103 (4 Suppl):385S-389S
12. Canto A, Ferrer G, Ramgosa V, et al. Lung cancer and pleural effusion: clinical significant and study of pleural metastatic locations. Chest 1985;87:649-652
13. Iranai DR, Underwood RD, Johnson EH, Greenberg SD. Malignant pleural effusions: a clinical cytopathologic study. Arch Intern Med 1987;147:1133-1136
14. Johnston WW. The malignant pleural effusion: a review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-909
15. Ruckdeschel JC. Management of malignant pleural effusion: an overview. Semin Oncol 1988;15:24-28
16. Tarver RD, Broderick LS, Conces DJ. Reexpansion pulmonary edema. J Thorac Imaging 1996;11:198-209
17. Mahfood S, Hix WR, Aaron BL, et al. Reexpansion pulmonary edema. Ann Thorac Surg 1988;45:340-345
18. Stretton F, Edmonds P, Marrinan M. Malignant pleural effusions. Eur J Palliative Care 1999;6:5-9
19. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant effusions. Cancer 1974;33:916-922
20. Izbicki R, Weyhing BT, Baker L, et al. Pleural effusion in cancer patients: a prospective randomized study of pleural drainage with the addition of radioactive phosphorus to the pleural space versus pleural drainage alone. Cancer 1975;36:1511-1518
21. Groth G, Gatzemeier U, Haubingen K, et al. Intrapleural palliative treatment of malignant pleural effusions with mitoxantrone versus placebo (pleural tube alone). Ann Oncol 1991;2:213-215
22. Antony VB. Pathogenesis of malignant pleural effusions and talc pleurodesis. Pneumologie 1999;53:493-498
23. Hewitt JB, Janssen WR. A management strategy for malignancy-induced pleural effusion: long-term thoracostomy drainage. Oncol Nurs Forum 1987;14:17-22
24. Patz EF, McAdams HP, Goodman PC, et al. Ambulatory sclerotherapy for malignant pleural effusions. Radiology 1996;199:133-135
25. Parker LA, Charnock GC, Delany DJ. Small bore catheter drainage and sclerotherapy for malignant pleural effusions. Cancer 1989;64:1218-1221
26. Morrison MC, Mueller PR, Lee MJ, et al. Sclerotherapy of malignant pleural effusion through sonographically placed small-bore catheters. AJR Am J Roentgenol 1992;158:41-43
27. Seaton KG, Patz EF Jr, Goodman PC. Palliative treatment of malignant pleural effusions: value of small-bore catheter thoracostomy and doxycycline sclerotherapy. AJR Am J Roentgenol 1995;164:589-591
28. Patz EF Jr, McAdams HP, Erasmus JJ, et al. Sclerotherapy for malignant pleural effusions: a prospective randomized trial of bleomycin vs doxycycline with small-bore catheter drainage. Chest 1998;113:1305-1311
29. Clementsen P, Evald T, Grode G, et al. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998;92:593-596
30. Adler RH, Sayek I. Treatment of malignant pleural effusion: a method using tube thoracostomy and talc. Ann Thorac Surg 1976;22:8-15
31. Villanueva AG, Gray AW Jr, Shahian DM, et al. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994;49:23-25
32. Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006;29:829-838
33. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997;112:430-434
34. Lynch TJ Jr, Kalish L, Mentzer SJ, et al. Optimal therapy of malignant pleural effusions: report of a randomized trial of bleomycin, tetracycline and talc and a meta-analysis. Int J Oncol 1996;8:183-190
35. Sherman S, Grady KJ, Seidman JC. Clinical experience with tetracycline pleurodesis of malignant pleural effusions. South Med J 1987;80:716-719
36. Bayly TC, Kisner DL, Sybert A, et al. Tetracycline and quinacrine in the control of malignant pleural effusions: a randomized trial. Cancer 1978;41:1188-1192
37. Martinez-Moragon E, Aparicio J, Rogado MC, et al. Pleurodesis in malignant pleural effusions: a randomized study of tetracycline versus bleomycin. Eur Respir J 1997;10:2380-2383
38. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994;106:342-346
39. Webb WR, Ozmen V, Moulder PV, et al. Iodized talc pleurodesis for the treatment of pleural effusions. J Thorac Cardiovasc Surg 1992;103:881-885
40. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993;106:689-695
41. Bitran JD, Brown C, Desser RK, et al. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol 1981;16:273-277
42. Ostrowski MJ, Halsall GM. Intracavitary bleomycin in the management of malignant effusions: a multicenter study. Cancer Treat Rep 1982;66:1903-1907
43. Heffner JE, Standerfer RJ, Torstveit J, et al. Clinical efficacy of doxycycline for pleurodesis. Chest 1994;105:1743-1747
44. Lorch DG, Gordon L, Wooten S, et al. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 1988;93:527-529
45. Dryzer SR, Allen ML, Strange C, Sahn SH. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993;104:1763-1766
46. Dresler CM, Olak J, Herndon JE II, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005;127:909-915
47. Sahn SA. Pleural diseases related to metastatic malignancies. Eur Respir J 1997;10:1907-1913
48. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996;62:1655-1658
49. Robinson LA, Fleming WH, Galbraith TA. Intrapleural doxycycline control of malignant pleural effusions. Ann Thorac Surg 1993;55:1115-1121
50. Pulsiripunya C, Youngchaiud P, Pushpakom R, et al. The efficacy of doxycycline as a pleural sclerosing agent in malignant pleural effusion: a prospective study. Respirology 1996;1:69-72
51. Janssen JP, Collier G, Astoul P, et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-1539
52. Hsu LH, Soong TC, Feng AC, Liu MC. Intrapleural urokinase for the treatment of loculated malignant pleural effusions and trapped lungs in medically inoperable cancer patients. J Thorac Oncol 2006;1:460-467
53. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde JJ, et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema. Chest 1996;109:1514-1519
54. Davies CWH, Traill ZC, Gleeson FV, et al. Intrapleural streptokinase in the management of malignant multiloculated pleural effusions. Chest 1999;115:729-733
55. Leff RS, Eisenberg B, Baisden CE, Mosley KR, Messerschmidt GL. Drainage of recurrent pleural effusion via an implanted port and intrapleural catheter. Ann Intern Med 1986;104:208-209
56. Zeldin DC, Rodriguez RM, Glassford DM, Cutrell G, Newman JH. Management of refractory MPEs with a chronic indwelling pleural catheter. Chest 1991;100:87S
57. Robinson RD, Fullerton DA, Albert JD, Sorensen J, Johnston MR. Use of pleural Tenckhoff catheter to palliate malignant pleural effusion. Ann Thorac Surg 1994;57:286-288
58. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999;86:1992-1999
59. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000;69:369-375
60. Smart JM, Tung KT. Initial experiences with a long-term indwelling tunnelled pleural catheter for the management of malignant pleural effusion. Clin Radiol 2000;55:882-884
61. Pollak JS, Burdge CM, Rosenblatt M, Houston JP, Hwu WJ, Murren J. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 2001;12:201-208
62. Musani AI, Haas A, Seijo L, et al. Outpatient management of malignant pleural effusions with a tunneled pleural catheter: pleurodesis without sclerosing agents. Respiration 2004;71:559-566
63. Pien GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001;119:1641-1646
64. Ohm C, Park D, Vogen M, et al. Use of an indwelling pleural catheter compared with thorascopic talc pleurodesis in the management of pleural effusions. Am Surg 2003;69:198-202; discussion 202
65. Tremblay A, Michaud G. Single-center experience with 250 tunneled pleural catheter insertions for malignant pleural effusion. Chest 2006;129:362-368
66. Reed DN Jr, Vyskocil JJ, Rao V. Subcutaneous access ports with fenestrated catheters for improved management of recurrent pleural effusions. Am J Surg 1999;177:145-146
67. Daniel C, Kriegel I, Di Maria S, et al. Use of a pleural implantable access system for the management of malignant pleural effusion: the Institut Curie experience. Ann Thorac Surg 2007;84:1367-1370